SCHEMBL30212486

SCHEMBL30212486

c1ccc(OCc2ccnc(-n3cncn3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.47
CYSLTR2 Q9NS75 1/20 0.42
CYSLTR1 Q9Y271 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 4/20 0.40
MAPT P10636 3/20 0.40
TP53 P04637 2/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 1/20 0.39
MAPK10 P53779 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24921059 0.82 CYP1A2 (0.38) SMN1; SMN2CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24921660 0.80 CYP1A2 (0.38) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL30212206 0.79 KCNH2 (0.54) KCNH2CYSLTR2CYSLTR1NPC1RAB9A
SCHEMBL30212372 0.77 KCNH2 (0.49) KCNH2CYSLTR2CYSLTR1NPC1RAB9A
SCHEMBL22325530 0.70 ALKBH1 (0.56) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL3625207 0.70 CYP2A6 (0.41) SMN1; SMN2LMNAMAPTCYP1A2CYP2D6
SCHEMBL4667925 0.69 RAB9A (0.62) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL20746692 0.68 KCNH2 (0.61) KCNH2CYSLTR2CYSLTR1NPC1RAB9A
SCHEMBL2666365 0.68 CYP2A6 (0.40) SMN1; SMN2LMNAMAPTCYP1A2CYP2D6
SCHEMBL17898216 0.68 KCNH2 (0.61) KCNH2CYSLTR2CYSLTR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed